FDA Clearance Tracker · P180025-S012
MANTA Vascular Closure Device, 14F, MANTA Vascular Closure Device, 18F, MANTA 8F Depth Locator, MANTA 14F Depth Locator
Last checked: Nov 20, 2026Latest source record: Jun 7, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jun 7, 2024
Approved
Time to decision
63 days
Received Apr 5, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P180025-S012
- Device name
- MANTA Vascular Closure Device, 14F, MANTA Vascular Closure Device, 18F, MANTA 8F Depth Locator, MANTA 14F Depth Locator
- Applicant
- Teleflex Medical, LLC
- Applicant location
- Morrisville, NC
- Received
- Apr 5, 2024
- Decided
- Jun 7, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P180025
Device type
- Device type
- Device, hemostasis, vascular (MGB)
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the following manufacturing sites:Vascular Solutions LLC6464 Sycamore Court NorthMinneapolis, MN 55369Teleflex LLC North American Distribution Center (NADC)11245 N. Distribution CoveOlive Branch, MS 38654
Source documents
Other decisions for Teleflex Medical, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262531 · Decided Oct 27, 2026 · 97 days after receipt
Device type: Instrument, Biopsy (KNW) · GI, Urology & Nephrology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.